(PharmaNewsWire.Com, September 30, 2021 ) The global sugar substitutes market size is estimated to be valued at USD 16.5 billion in 2020 and projected to reach USD 20.6 billion by 2025, recording a CAGR of 4.5% during the forecast period.
The global sugar substitute industry has witnessed growing trends in the past years. The growth of this industry is majorly driven by an increase in health consciousness among consumers to encourage the demand for healthier food choices, an increase in demand for natural sweeteners due to the rise in consumer inclination toward natural products, and growing demand for sugar substitutes in various applications in the food & beverage industry.
Based on type, the sugar substitutes market is dominated by the high-intensity sweeteners segment. High-intensity sweeteners are the ingredients used for enhancing the sweetness and flavor of food products. They are sweeter than table sugar or sucrose. Due to this, smaller amounts of high-intensity sweeteners are enough for achieving the same level of sweetness as sugar in food products. High-intensity sweeteners do not contribute calories or only contribute a few calories to the diet. They also generally will not raise blood sugar levels.
By composition, the stevia segment is projected to witness the fastest growth in the sugar substitutes market in high-intensity sweeteners for the period forecasted. Stevia is a plant that is cultivated in South American countries, including Paraguay and Brazil. It is used as a sweetener for many years. Stevia is a zero-calorie sweetener and is used globally for reducing energy and adding sugar content in food and beverage products. Stevia is sourced naturally and has been used as a natural sugar substitute and flavoring ingredient in food and beverage applications.
By composition, the D-tagtose segment is projected to witness the fastest growth in the sugar substitiutes market in low-intensity sweeteners for the period forecasted. D-Tagatose is a functional sweetener and is generally used in dairy products. It is similar in texture to table sugar and is 92% as sweet as sugar but has nearly 38% of calories. However, along with containing a low amount of calories and net carbs than sugar, D-tagatose is also a low glycemic index food product.
This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as DuPont (US), ADM (US), Tate & Lyle (UK), Ingredion Incorporated (US), Cargill Incorporated (US), Roquette Frčres (France), PureCircle Ltd (US), MacAndrews & Forbes Holdings Inc. (US), JK Sucralose Inc. (China), and Ajinomoto Co. Inc. (Japan).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
